Stay updated on Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0. The study record is still showing a 403 Forbidden error.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAn NIH-wide notice about website changes appears above the page, and the site revision advances from v3.7.1 to v3.7.2; the study record still displays a 403 error.SummaryDifference1%

- Check28 days agoChange DetectedThe footer’s site revision changes from v3.7.0 to v3.7.1, while the page still displays a 403 error instead of the study record.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page for the study NCT02753127 on ClinicalTrials.gov now shows a 403 Forbidden error instead of the usual content. This indicates the record is currently inaccessible.SummaryDifference18%

- Check49 days agoChange DetectedA new revision tag, v3.7.0, was added and the previous tag v3.6.6 was removed. This reflects an update to the page version rather than changes to the study information.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded Tel Litwinsky, Israel, 52621 as a study site. Removed Qiryat Krinitzi, Israel, 52621 from the site list.SummaryDifference0.1%

Stay in the know with updates to Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial page.